NO20014645D0 - Fremgangsmåte for fremstilling av 3,4-dihydroproliner og 3,4- dehydropiperidiner - Google Patents

Fremgangsmåte for fremstilling av 3,4-dihydroproliner og 3,4- dehydropiperidiner

Info

Publication number
NO20014645D0
NO20014645D0 NO20014645A NO20014645A NO20014645D0 NO 20014645 D0 NO20014645 D0 NO 20014645D0 NO 20014645 A NO20014645 A NO 20014645A NO 20014645 A NO20014645 A NO 20014645A NO 20014645 D0 NO20014645 D0 NO 20014645D0
Authority
NO
Norway
Prior art keywords
alkyl
dihydroprolines
dehydropiperidines
preparation
hydrogen
Prior art date
Application number
NO20014645A
Other languages
English (en)
Norwegian (no)
Other versions
NO20014645L (no
Inventor
Bernd Schaefer
Guenter Helmchen
Uli Kazmaier
Simone Schleich
Helmut Stahr
Volker Wolfart
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of NO20014645L publication Critical patent/NO20014645L/no
Publication of NO20014645D0 publication Critical patent/NO20014645D0/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/20Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20014645A 1999-03-26 2001-09-25 Fremgangsmåte for fremstilling av 3,4-dihydroproliner og 3,4- dehydropiperidiner NO20014645D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19913699A DE19913699A1 (de) 1999-03-26 1999-03-26 Verfahren zur Herstellung von 3,4-Dihydroprolinen und 3,4-Dehydropiperidinen
PCT/EP2000/002377 WO2000058284A1 (de) 1999-03-26 2000-03-17 Verfahren zur herstellung von n-acyl-3,4 - dehydroprolin und n-acyl-3,4 - dehydropiperidin-2-carbonsäure derivaten

Publications (2)

Publication Number Publication Date
NO20014645L NO20014645L (no) 2001-09-25
NO20014645D0 true NO20014645D0 (no) 2001-09-25

Family

ID=7902464

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014645A NO20014645D0 (no) 1999-03-26 2001-09-25 Fremgangsmåte for fremstilling av 3,4-dihydroproliner og 3,4- dehydropiperidiner

Country Status (22)

Country Link
US (1) US6579971B1 (enExample)
EP (1) EP1165509B1 (enExample)
JP (1) JP3868210B2 (enExample)
KR (1) KR20010104730A (enExample)
CN (1) CN1345310A (enExample)
AT (1) ATE278665T1 (enExample)
AU (1) AU3962500A (enExample)
BR (1) BR0009330A (enExample)
CA (1) CA2368479C (enExample)
CZ (1) CZ20013456A3 (enExample)
DE (2) DE19913699A1 (enExample)
ES (1) ES2230088T3 (enExample)
HK (1) HK1045156A1 (enExample)
HU (1) HUP0200420A2 (enExample)
IL (1) IL145525A0 (enExample)
MX (1) MXPA01009679A (enExample)
NO (1) NO20014645D0 (enExample)
RU (1) RU2001129097A (enExample)
TR (1) TR200102747T2 (enExample)
TW (1) TWI276626B (enExample)
WO (1) WO2000058284A1 (enExample)
ZA (1) ZA200107629B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100396666C (zh) * 2005-12-14 2008-06-25 郑州大学 (4s)-1-叔丁氧羰基-4-氨基-l-脯氨酸乙酯及其合成工艺

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4291040A (en) * 1979-10-22 1981-09-22 E. R. Squibb & Sons, Inc. Mercaptoacyl derivatives of 4-disubstituted prolines and 4-substituted dehydroprolines
US5580575A (en) 1989-12-22 1996-12-03 Imarx Pharmaceutical Corp. Therapeutic drug delivery systems
DE59409568D1 (de) 1993-09-09 2000-11-30 Schering Ag Wirkstoffe und gas enthaltende mikropartikel
DE19630082A1 (de) * 1996-07-26 1998-01-29 Basf Ag Verfahren zur Herstellung von 3-Pyrrolin-2-carbonsäure-Derivaten
US6090800A (en) 1997-05-06 2000-07-18 Imarx Pharmaceutical Corp. Lipid soluble steroid prodrugs
DE19723473A1 (de) * 1997-06-04 1998-12-10 Basf Ag Verfahren zur Herstellung von chiralen 3,4-Didehydroprolinen
DE69925461T2 (de) 1998-02-09 2006-04-27 Bracco International B.V. Zielgerichtete abgabe von biologische-aktive medien

Also Published As

Publication number Publication date
US6579971B1 (en) 2003-06-17
WO2000058284A1 (de) 2000-10-05
HUP0200420A2 (hu) 2002-05-29
DE50008117D1 (de) 2004-11-11
NO20014645L (no) 2001-09-25
IL145525A0 (en) 2002-06-30
MXPA01009679A (es) 2002-03-14
TR200102747T2 (tr) 2002-02-21
ATE278665T1 (de) 2004-10-15
CA2368479C (en) 2005-03-01
CN1345310A (zh) 2002-04-17
JP3868210B2 (ja) 2007-01-17
BR0009330A (pt) 2002-01-08
EP1165509B1 (de) 2004-10-06
EP1165509A1 (de) 2002-01-02
DE19913699A1 (de) 2000-09-28
CZ20013456A3 (cs) 2002-05-15
JP2002540190A (ja) 2002-11-26
TWI276626B (en) 2007-03-21
RU2001129097A (ru) 2004-03-20
AU3962500A (en) 2000-10-16
KR20010104730A (ko) 2001-11-26
ZA200107629B (en) 2002-09-17
HK1045156A1 (zh) 2002-11-15
CA2368479A1 (en) 2000-10-05
ES2230088T3 (es) 2005-05-01

Similar Documents

Publication Publication Date Title
TW197936B (enExample)
GB9822473D0 (en) Chemical compounds
MY138525A (en) Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
MY120090A (en) Chemical compounds.
BG104670A (en) 4-(2-keto-1-benzimidazolinyl)piperidinne compounds as orl1-receptor agonists
GB2391232A (en) Biodegradable films having enhanced ductility and breathability
AU6613896A (en) Chemical compounds
CA2313122A1 (en) Bicycliccarbonyl indole compounds as anti-inflammatory/analgesic agents
CA2424879A1 (en) Cleaning compositions containing chitosan
MY117092A (en) Chemotherapeutic pyrrolocarbazole derivatives
NZ516454A (en) Titanium compounds, preparation and use thereof
NO981393L (no) Guanidinoproteasehemmere
EP0243834A3 (en) Substituted oxime ethers; their use as bioregulators for lowering the endogene ethylene level in plants
NO20014645L (no) Fremgangsmåte for fremstilling av 3,4-dihydroproliner og 3,4- dehydropiperidiner
YU18801A (sh) Eletriptan hidrobromid monohidrat
AU684327B2 (en) Bridged cyclopentadienylmagnesium compounds and process for the preparation thereof and use thereof for preparing metallocenes
TW360658B (en) Novel water-soluble fluoroethylcamptothecin derivative and process for production thereof
AU2001261707A1 (en) Pirazino '1$m(1)2$m(1) :1, 6! pyrido '3,4-b! indole derivatives
AU6699600A (en) Formulations of fluorescent whitening agents
MY130488A (en) Process for preparing 3,3',6,6'-tetraalkyl-2,2'-biphenols and 3,3',6,6'-tetraalkyl-5,5'-dihalo-2,2'-biphenols
MX9804828A (es) Benzotiazolona etanaminas biologicamente activas.
AU6520196A (en) Aqueous compositions containing ciprofloxacine, and related use and process
CA2405892A1 (en) Substituted caprolactam carbonates and ethers and their use as anti-tumor agents
AU6234296A (en) Therapeutic compounds
EP1203763A3 (de) Beta-Hydroxyalkylamide, Verfahren zu ihrer Herstellung und deren Verwendung